Virax Biolabs Group (Virax Biolabs Group) Other Current Liabilities : $0.22 Mil (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group Other Current Liabilities?

Virax Biolabs Group's other current liabilities for the quarter that ended in Sep. 2023 was $0.22 Mil.

Virax Biolabs Group's quarterly other current liabilities increased from Sep. 2022 ($0.00 Mil) to Mar. 2023 ($0.41 Mil) but then declined from Mar. 2023 ($0.41 Mil) to Sep. 2023 ($0.22 Mil).

Virax Biolabs Group's annual other current liabilities stayed the same from Mar. 2021 ($0.00 Mil) to Mar. 2022 ($0.00 Mil) but then increased from Mar. 2022 ($0.00 Mil) to Mar. 2023 ($0.41 Mil).

Virax Biolabs Group Other Current Liabilities Historical Data

The historical data trend for Virax Biolabs Group's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group Other Current Liabilities Chart

Virax Biolabs Group Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Other Current Liabilities

Virax Biolabs Group Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Other Current Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

Virax Biolabs Group Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Virax Biolabs Group Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Virax Biolabs Group (Virax Biolabs Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 North Audley Street, London, GBR, W1K 6LX

Website

https://www.viraxbiolabs.com

Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.